What is happening to Medicare Part D in 2027?


Editorial team Published on

In 2027, Medicare Part D is changing through an increase in the out-of-pocket maximum, the expiration of temporary federal premium stabilization subsidies, and the implementation of newly negotiated maximum fair prices for additional prescription drugs. You can review and compare your options on the official Medicare Plan Finder.

Key Cost and Policy Changes

  • Out-of-Pocket Cap: The annual maximum out-of-pocket spending limit for covered Part D prescription drugs rises from $2,100 to $2,400. Once you reach this limit, your covered drugs cost $0 for the rest of the year.
  • Deductible Increase: The standard Part D prescription drug deductible increases to $700, up from $615 in 2026.
  • Expiration of Premium Subsidies: The temporary Part D Premium Stabilization Demonstration program concludes on December 31, 2026. Without this federal support, stand-alone prescription drug plans may see varied premium adjustments.
  • Drug Price Negotiations: Maximum fair prices for 15 additional negotiated brand-name drugs take effect on January 1, 2027, following the initial group introduced in 2026.
  • Base Beneficiary Premium: The calculated base beneficiary premium is set at $41.33 for 2027, with annual growth protected by statutory caps.

What You Should Do

  • Open Enrollment: The annual enrollment period runs from October 15 to December 7, 2026, for coverage beginning January 1, 2027.
  • Check Documents: Carefully read your Annual Notice of Change (ANOC) letter sent by your current plan provider to see adjustments in your specific formulary tiers, preferred pharmacies, and monthly costs.